Rationale and design of the Oxycodone Users Registry: A prospective, multicenter registry of patients with nonmalignant pain

Journal of Opioid Management

Volumn 9, Issue 3, 2013, Pages 189-204

  Kim, Myoung ^a   Chow, Wing ^a   Benson, Carmela ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Design; Opioid; Oxycodone; Rationale; Registry

Indexed keywords

DIAMORPHINE; MORPHINE; OXYCODONE;

ACUTE CORONARY SYNDROME; ARTHRITIS; ARTICLE; BRIEF PAIN INVENTORY; CANCER PAIN; CEREBROVASCULAR ACCIDENT; CONCEPTUAL FRAMEWORK; FIBROMYALGIA; HEAD INJURY; HEART FAILURE; HUMAN; INJURY; LIMB INJURY; LOW BACK PAIN; MAJOR CLINICAL STUDY; MONOTHERAPY; NECK INJURY; NEUROPATHIC PAIN; NONMALIGNANT PAIN; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; OXYCODONE USER REGISTRY; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; POSTOPERATIVE PAIN; PRESCRIPTION; REGISTER; THORAX INJURY;

ADULT; AGED; ANALGESICS, OPIOID; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYCODONE; PAIN; PROSPECTIVE STUDIES; REGISTRIES; RESEARCH DESIGN;

EID: 84882345492     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2013.0160     Document Type: Article

References (64)

1. Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User's Guide. 2nd ed. AHRQ Publication No.10-EHC049. Rockville, MD: Agency for Healthcare Research and Quality, 2010.
2. Lapane KL, Quilliam BJ, Benson C, et al.: Gastrointestinal events after opioid treatment in non-malignant pain: Correlates of occurrence and impact on health related quality of life. J Opioid Manag. 2013; 9: 205-216.
3. Caudill-Slosberg MA, Schwartz LM, Woloshin S: Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004; 109: 514-519.
4. Manchikanti L, Singh A: Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Phys. 2008; 11: S63-88.
5. Katz WA, Barkin RL: Dilemmas in chronic/persistent pain management. Am J Ther. 2008; 15: 256-264.
6. Harris JD: Management of expected and unexpected opioid-related side effects. Clin J Pain. 2008; 24 (Suppl 10): S8-S13.
7. Swegle JM, Logemann C: Management of common opioid-induced adverse effects. Am Fam Phys. 2006; 74:1347-1354.
8. Oderda GM, Evans RS, Lloyd J, et al.: Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage. 2003; 25: 276-283.
9. Bell T, Milanova T, Grove G, et al.: OBD symptoms impair quality of life and daily activities, regardless of frequency and duration of opioid treatment: Results of a US patient survey (PROBE survey). J Pain. 2007; 8(Suppl 1): S71.
10. VanDenKerkhof EG, Hopinan WM, Towheed T, et al.: Pain, health-related quality of life and health care utilization after inpatient surgery: A pilot study. Pain Res Manag. 2006; 11: 41-47.
11. Aparasu R, McCoy RA, Weber C, et al.: Opioid-induced eme-sis among hospitalized nonsurgical patients: Effect on pain and quality of life. J Pain Symptom Manage. 1999; 18: 280-288.
12. Kwong W, Gasik A, Voeller S, et al.: Importance of opioid side effects in pain management from patient perspective. J Pain. 2009; 10(Suppl 1): S51.
13. White PF: Management of postoperative pain and emesis. Can J Anaesth. 1995; 42:1053-1055.
14. Burke JP, Pestotnik SL, Classen DC, et al.: Evaluation of the financial impact of ketorolac tromethamine therapy in hospitalized patients. Clin Ther. 1996; 18: 197-211.
15. Stephens J, Laskin B, Pashos C, et al.: The burden of acute postoperative pain and the potential role of the COX-2-specifîc inhibitors. Rheumatology (Oxford). 2003; 42 Suppl 3: iii40-52.
16. Stewart WF, Ricci JA, Chee E, et al.: Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003; 290: 2443-2454.
17. Ricci JA, Stewart WF, Chee E, et al.: Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum. 2005; 53: 673-681.
18. Beauregard L, Pomp A, Choiniere M: Severity and impact of pain after day-surgery. Can JAnaesth. 1998; 45: 304-311.
19. Katz JN: Lumbar disc disorders and low-back pain: Socioeconomic factors and consequences. J Bone Joint Surg Am. 2006; 88 (Suppl 2): 21-24.
20. Henschke N, Maher CG, Refshauge KM, et al.: Prognosis in patients with recent onset low back pain in Australian primary care: Inception cohort study. BMJ. 2008; 337: a171.
21. Manchikanti L, Singh V, Smith HS, et al.: Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 4: Observational studies. Pain Phys. 2009; 12: 73-108.
22. Vogt MT, Kwoh CK, Cope DK, et al.: Analgesic usage for low back pain: Impact on health care costs and service use. Spine. 2005; 30: 1075-1081.
23. Webster BS, Verma SK, Gatchel RJ: Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine. 2007; 32: 2127-2132.
24. Franklin GM, Stover BD, Turner JA, et al.: Early opioid prescription and subsequent disability among workers with back injuries: The Disability Risk Identification Study Cohort. Spine. 2008; 33: 199-204.
25. Gross DP, Stephens B, Bhambhani Y, et al.: Opioid prescriptions in Canadian workers' compensation claimants: Prescription trends and associations between early prescription and future recovery. Spine. 2009; 34: 525-531.
26. Sadowski CA, Carrie AG, Grymonpre RE, et al.: Access and intensity of use of prescription analgesics among older Manitobans. Can J Clin Pharmacol. 2009; 16: e322-330.
27. Peacock WF, Hollander JE, Diercks DB, et al.: Morphine and outcomes in acute decompensated heart failure: An ADHERE analysis. Emerg Med J. 2008; 25: 205-209.
28. Engeland A, Skurtveit S, Morland J: Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. Ann Epidemiol. KXil; 17: 597-602.
29. Dowling K, Storr CL, Chilcoat HD: Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population. Clin J Pain. 2006; 22:776-783.
30. Chinellato A, Terrazzani G, Debetto P, et al.: Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian region. Br J Clin Pharmacol. 2006; 62:130-133.
31. Jauncey ME, Taylor LK, Degenhardt LJ: The definition of opioid-related deaths in Australia: Implications for surveillance and policy. Drug Alcohol Rev. 2005; 24: 401-409.
32. Meine TJ, Roe MT, Chen AY, et al.: Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005; 149: 1043-1049.
33. Jarlbaek L, Andersen M, Hallas J, et al.: Use of opioids in a Danish population-based cohort of cancer patients. J Pain Symptom Manage. 2005; 29: 336-343.
34. Herrera E, Rocafort J, De Lima L, et al.: Regional palliative care program in Extremadura: An effective public health care model in a sparsely populated region. J Pain Symptom Manage. 2007; 33: 591-598.
35. Zorowitz RD, Smout RJ, Gassaway JA, et al.: Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). Top Stroke Rehabil. 2005; 12: 37-49.
36. Murphy BA, Chen A, Curran WJ jr, et al.: Longitudinal oncology registry of head and neck carcinoma (LORHAN((R))): Initial supportive care findings. Support Care Cancer. 2009; 17(11): 1393-1401.
37. Jarlbaek L, Andersen M, Kragstrup J, et al.: Cancer patients' share in a population's use of opioids. A linkage study between a prescription database and the Danish Cancer Registry. J Pain Symptom Manage. 2004; 27: 36-43.
38. Kashiwagi M, Arlettaz R, Lauper U, et al.: Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand. 2005; 84:140-144.
39. Arlettaz R, Kashiwagi M, Das-Kundu S, et al.: Methadone maintenance program in pregnancy in a Swiss perinatal center (II): Neonatal outcome and social resources. Acta Obstet Gynecol Scand. 2005; 84: 145-150.
40. Strike CJ, Gnam W, Urbanoski K, et al.: Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence. Addict Behav. 2005; 30:1025-1028.
41. Rehm J, Frick U, Hartwig C, et al.: Mortality in heroin-assisted treatment in Switzedand 1994-2000. Drug Alcohol Depend. 2005; 79: 137-143.
42. Gibson AE, Degenhardt LJ: Mortality related to pharmacotherapies for opioid dependence: A comparative analysis of coronial records. Drug Alcohol Rev. 2007; 26: 405-410.
43. Sims SA, Snow LA, Porucznik CA: Surveillance of methadone-related adverse drug events using multiple public health data sources. J Biomed Inform. 2007; 40: 382-389.
44. Clausen T, Anchersen K, Waal H: Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug Alcohol Depend. 2008; 94: 151-157.
45. Nordt C, Stohler R: Estimating heroin epidemics with data of patients in methadone maintenance treatment, collected during a single treatment day. Addiction. 2008; 103: 591-597.
46. Davstad I, Stenbacka M, Leifman A, et al: An 18-year follow-up of patients admitted to methadone treatment for the first time. J Addict Dis. 2009; 28: 39-52.
47. Deer T, Chappie I, Classen A, et al.: Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Med. 2004; 5: 6-13
48. Ilias W, le Polain B, Buchser E, et al.: Patient-controlled analgesia in chronic pain patients: Experience with a new device designed to be used with implanted programmable pumps. Pain Pract. 2008; 8:164-170.
49. Portenoy RK, Farrar JT, Backonja MM, et al.: Long-term use of controlled-release oxycodone for noncancer pain: Results of a 3-year registry study. Clin J Pain. 2007; 23: 287-299.
50. Anastassopoulos KP, Chow W, Ackerman SJ, et al.: Oxycodone-related side effects: Impact on degree of bother, adherence, pain relief, satisfaction, and quality of life. J Opioid Manag. 2011; 7: 203-215.
51. Hale M, Upmalis D, Okamoto A, et al.: Tolerability of tapen-tadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: A randomized, double-blind study. Curr Med Res Opin. 2009; 25: 1095-1104.
52. Farrar JT, Young JP, Jr., LaMoreaux L, et al.: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001; 94:149-158.
53. Farrar JT, Berlin JA, Strom BL: Clinically important changes in acute pain outcome measures: A validation study. J Pain Symptom Manage. 2003; 25: 406-411.
54. Farrar JT, Portenoy RK, Bedin JA, et al.: Defining the clinically important difference in pain outcome measures. Pain. 2000; 88: 287-294.
55. Portenoy RK, Thaler HT, Kornblith AB, et al.: The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. Rur J Cancer. 1994; 30A: 1326-1336.
56. Apfelbaum JL, Gan TJ, Zhao S, et al.: Reliability and validity of the perioperative opioid-related symptom distress scale. Anesth Analg. 2004; 99: 699-709.
57. Casarett D, Kariawish J, Sankar P, et al.: Designing pain research from the patient's perspective: What trial end points are important to patients with chronic pain? Pain Med. 2001; 2:309-316.
58. Hays R, Stewart A. Sleep measures. In: Stewart A, Ware J, eds. Measuring Functioning and Weil-Being: the Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992: 235-259.
59. Keller S, Bann CM, Dodd SL, et al.: Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004; 20: 309-318.
60. Ware J, Jr., Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34: 220-233
61. Lerner D, Amick BC III, Rogers WH, et al.: The Work Limitations Questionnaire. Med Care. 2001; 39: 72-85.
62. Poole HM, Murphy P, Nurmikko TJ: Development and preliminary validation of the NePIQoL: A quality-of-life measure for neuropathic pain, y Pain Symptom Manage. 2009; 37: 233-245.
63. Douglas C, Windsor C, Wollin J: Understanding chronic pain complicating disability: Finding meaning through focus group methodology. J Neurosci Niirs. 2008; 40:158-168.
64. Jacobson AF, Myerscough RP, Delambo K, et al.: Patients' perspectives on total knee replacement. Am J Nurs. 2008; 108: 54-63; quiz 63-54.